Dividend Track Records

On December 8, 2025, Eli Lilly (LLY) announced a significant 15.3% dividend increase , lifting its quarterly payout to $1.73 per share . With shares trading at $997 , the new rate represents a forward yield of about 0.7% . The company has now delivered 12 consecutive years of dividend growth and is recognized as a Dividend Hero .

On December 9, 2024, Eli Lilly (LLY) announced a 15% dividend increase together with a new $15 billion buyback program. This marks the 7th consecutive year with a 15% increase by LLY.

Lamb Weston hiked the dividend by 28.6% in 2023. The biggest dividend hike in week 50 was announced by potato products supplier Lamb Weston , with a 28.6% increase. Other interesting companies announcing dividend hikes include Pfizer, Eli Lilly, Waste Management, Realty Income en multiple Dividend Aristocrats . Also we had special dividend announcements by Costco and W.R. Berkley. 

Some interesting stuff going on with pharmaceutical giant Eli Lilly this week surpassing Dividend Aristocrat Johnson & Johnson (JNJ) as the biggest player in the sector based on market cap.  Eli Lilly (ticker LLY) is now worth $445 billion versus $430 billion for JNJ. Even more interesting is the dividend of these two giants, with Eli Lilly 's dividend growing much faster in the last five years.

On December 12, 2022, Eli Lilly and Company (LLY) announced a new quarterly dividend of $1.13 per share, up 15.3% from the previous quarterly dividend of $0.98 per share. The pharmaceutical company has now raised its dividend for 9 consecutive years with similar 15% dividend hikes in the previous couple of years. The next LLY dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023. The new annual indicated rate to $4.52 per share, yields 1.2% at a stock price of $367. Eli Lilly and Company is a manufacturer of human pharmaceutical products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. In the U.S., most of Lilly's pharmaceutical products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Outside the U.S, the company promotes its products to healthcare p...

Eli Lilly and Company (LLY) will raise its dividend by 15.3 percent to 98 cents per share. This follows a dividend hike of 14.9 percent to $0.85 per share in the first quarter of 2021. The pharmaceutical company has now raised its dividend for 8 consecutive years. The next LLY dividend is payable March 10, 2022, to shareholders of record as of the close of business on February 15, 2022. The new annual indicated rate to $3.92 per share, yields 1.6% at a stock price of $271.40. Eli Lilly and Company is a manufacturer of human pharmaceutical products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. In the U.S., most of Lilly's pharmaceutical products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Outside the U.S, the company promotes its products to healthcare providers primarily through sales represen...

Just like last year Eli Lilly and Company (LLY) will raise its dividend by 14.7 percent to $0.85 per share in the first quarter of 2021. Last year the company announced a 14.7 percent dividend hike, matching the 2018 increase. The pharmaceutical company has now raised its dividend for 7 consecutive years. The next dividend is payable March 10, 2021, to shareholders of record as of the close of business on February 12, 2021. The new annual indicated rate to $3.40 per share, yields 2.0% at a stock price of $171.40. The stock price of Eli Lilly and Company has gained 30.4 percent in 2020, outperforming most large cap farmaceutical peers and resulting in a market cap of $164 billion with the stock trading near its all time high. Eli Lilly now pays an estimated $3.2 billion in dividends annually to shareholders with dividend growth picking up in the last three years with a double digit increase announced in 2018, 2019 and 2020. Eli Lilly and Company is a manufacturer of human pharmaceut...